Lipid Mediator Dysregulation in Primary Pulmonary Hypertension

This publication has 10 references indexed in Scilit:

• Low-affinity thromboxane receptor mediates proliferation in cultured vascular smooth muscle cells of rats.
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
  New England Journal of Medicine, 1996
• An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension
  New England Journal of Medicine, 1992
• U-61, 431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells
  Prostaglandins, 1991
• Decreased Arterial Wall Prostaglandin Production in Neonatal Calves with Severe Chronic Pulmonary Hypertension
  American Journal of Respiratory Cell and Molecular Biology, 1989
• Heterogeneity of Pathologic Lesions in Familial Primary Pulmonary Hypertension
  American Review of Respiratory Disease, 1988
• Thromboxane Synthetase Inhibition in Primary Pulmonary Hypertension
  Chest, 1987
• Prostaglandin Biosynthesis and its Compartmentation in Vascular Smooth Muscle and Endothelial Cells
  Annual Review of Physiology, 1986
• 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
  Proceedings of the National Academy of Sciences, 1986
• Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium
  Blood, 1979